TScan Therapeutics Market Cap

TScan Therapeutics has a market cap or net worth of $297.39 million as of April 19, 2024. Its market cap has increased by 539.55% in one year.

Market Cap

297.39M

Enterprise Value

192.75M

1-Year Change

539.55%

Ranking

#3331

Market Cap Chart

Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $297.39M, a decrease of -17.18%. That is a compound annual growth rate of -6.60%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	331.30M	2.51%
Apr 17, 2024	323.20M	-5.33%
Apr 16, 2024	341.40M	-7.28%
Apr 15, 2024	368.20M	-0.78%
Apr 12, 2024	371.10M	-0.64%
Apr 11, 2024	373.50M	7.89%
Apr 10, 2024	346.20M	-2.94%
Apr 9, 2024	356.70M	1.48%
Apr 8, 2024	351.50M	3.53%
Apr 5, 2024	339.50M	-
Apr 4, 2024	339.50M	-0.96%
Apr 3, 2024	342.80M	-0.58%
Apr 2, 2024	344.80M	-10.09%
Apr 1, 2024	383.50M	0.87%
Mar 28, 2024	380.20M	-4.33%
Mar 27, 2024	397.40M	3.87%
Mar 26, 2024	382.60M	0.76%
Mar 25, 2024	379.70M	-1.12%
Mar 22, 2024	384.00M	14.39%
Mar 21, 2024	335.70M	-
Mar 20, 2024	335.70M	0.60%
Mar 19, 2024	333.70M	2.05%
Mar 18, 2024	327.00M	-4.08%
Mar 15, 2024	340.90M	4.86%
Mar 14, 2024	325.10M	1.18%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Atea Pharmaceuticals	311.41M
Sera Prognostics	307.97M
Anavex Life Sciences	307.18M
Procaps Group	304.62M
Rani Therapeutics Holdings	303.45M
Viemed Healthcare	300.21M
Spok Holdings	299.83M
Nyxoah	298.08M

Market Cap Rankings